tailieunhanh - Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response

Breast cancer with pathological non-complete response (non-pCR) after neoadjuvant chemotherapy (NAC) has a worse prognosis. Despite Neo-Bioscore has been validated as an independent prognostic model for breast cancer submitted to NAC, non-pCR carcinoma was not assessed in this setting. | Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN